Medicare Enrolled
Dr. Alexander Drtil, MD
Cardiovascular Disease · Houston, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Drtil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Drtil? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Drtil
Dr. Alexander Drtil is a cardiovascular disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Drtil performed 7,143 Medicare services across 3,749 unique beneficiaries.
Between the years covered by Open Payments, Dr. Drtil received a total of $156,278 from 21 pharmaceutical and/or device companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Drtil is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 8% volume in TX$ $156,278 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,143
Medicare services
Top 8% in TX for cardiovascular disease
3,749
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~357 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 816 | $20 | $28 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 787 | $29 | $37 |
| Remote pacemaker/defibrillator monitoring, 90 days | 767 | $17 | $27 |
| Office visit, established patient (30-39 min) | 500 | $101 | $134 |
| Electrocardiogram (EKG), 12-lead | 485 | $10 | $15 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 461 | $9 | $13 |
| Remote pacemaker monitoring, 90 days | 426 | $22 | $35 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 383 | $20 | $29 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 355 | $5 | $8 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 342 | $27 | $69 |
| Office visit, established patient (20-29 min) | 221 | $54 | $95 |
| Evaluation of implantable heart and blood vessel monitoring system | 148 | $16 | $23 |
| Programming of dual lead pacemaker system | 136 | $27 | $42 |
| Initial hospital admission, high complexity | 121 | $132 | $209 |
| EKG interpretation and report | 98 | $6 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 94 | $10 | $13 |
| Ultrasonic guidance for blood vessel access | 89 | $12 | $15 |
| Programming of multiple lead implantable defibrillator system | 82 | $45 | $66 |
| New patient office visit (45-59 min) | 82 | $125 | $189 |
| Hospital follow-up visit, high complexity | 79 | $85 | $108 |
| Echocardiogram, transthoracic | 78 | $49 | $77 |
| Programming of dual lead implantable defibrillator system | 64 | $41 | $96 |
| Hospital follow-up visit, moderate complexity | 64 | $49 | $75 |
| Evaluation of cardiac rhythm monitor system | 58 | $14 | $22 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 39 | $250 | $351 |
| Programming of heart rhythm stimulation after drug infusion | 34 | $67 | $116 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 32 | $760 | $1,156 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $250 | $350 |
| External shock to heart to regulate heart beat | 24 | $80 | $166 |
| Initial hospital admission, moderate complexity | 24 | $97 | $134 |
| Insertion of artery tube for blood sampling or infusion through skin | 22 | $36 | $53 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 20 | $40 | $128 |
| Hospital follow-up visit, low complexity | 19 | $31 | $40 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $417 | $589 |
| Repair of left upper heart chamber with implant with review by radiologist | 17 | $634 | $921 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $18 | $27 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 16 | $665 | $1,025 |
| Programming of multiple lead pacemaker system | 16 | $31 | $78 |
| Insertion of heart rhythm monitor under skin | 14 | $3,505 | $4,881 |
| Programming of single lead implantable defibrillator system | 14 | $26 | $45 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $68 | $237 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 13 | $125 | $162 |
| Insertion of implantable defibrillator system | 12 | $744 | $1,040 |
| Injection for x-ray imaging procedure into vein of arm or leg | 12 | $19 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.5% high complexity
0.2% medium
70.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$156,278
Total received (2018-2024)
Avg $22,325/year across 7 years
Top 4% in TX for cardiovascular disease
21
Companies
657
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$109,705 (70.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,188 (24.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,384 (5.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$17,702
2023$6,244
2022$5,467
2021$31,742
2020$17,255
2019$40,945
2018$36,922
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$109,705
Janssen Pharmaceuticals, Inc
$38,969
Medtronic Vascular, Inc.
$2,220
Biosense Webster, Inc.
$1,341
Medtronic, Inc.
$1,032
BOSTON SCIENTIFIC CORPORATION
$827
Boston Scientific Corporation
$596
E.R. Squibb & Sons, L.L.C.
$471
SANOFI-AVENTIS U.S. LLC
$381
BIOTRONIK INC.
$258
CARDIVA MEDICAL, INC.
$89
AltaThera Pharmaceuticals LLC
$84
Janssen Scientific Affairs, LLC
$70
Novartis Pharmaceuticals Corporation
$57
Amarin Pharma Inc.
$45
iRhythm Technologies, Inc.
$40
Preventice Services, LLC
$22
Aziyo Biologics, Inc.
$19
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
PFIZER INC.
$17
Bardy Diagnostics, Inc.
$16
Top 3 companies account for 96.6% of total payments
Associated products mentioned in payments ›
ACCENT · ACCOLADE SR · ALLURE · AMPLATZER Occluders · AMPLATZER TorqVue Delivery Systm · ASSURITY · ATTAIN COMMAND + SUREVALVE · AVEIR · AZURE XT DR MRI SURESCAN · Accent Pacemaker · Acticor · Acticor 7 VR-T DX · Advisa · Advisor Catheter · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Arctic Front · Assurity Pacemaker · Attain · Azure · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · COBALT DR MRI SURESCAN · CRT-Ds · CRT-Ps · Cardiac Mapping System · CareLink · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Carto CFAE · CartoSound · Cartomerge · Cartoreplay · Circular Mapping Catheters · Confirm Rx · Connectivity and Remote care · ECM Patch · ELIQUIS · EMBLEM MRI S-ICD · ENSITE PRECISION · ENTRESTO · EP-WorkMate Claris System · EVERA MRI XT DR SURESCAN · Edora · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · Evera · Fortify Assura · GALLANT · GENERAL - TACHY · General - Therapies · ICD Leads · ICDs · JOT DX · LATITUDE · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MITRACLIP · MRI Ready Leads · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · NA · ONYX FRONTIER · PULSESELECT · Pacemakers · Pouch · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · RESONATE · RHYTHMIA · Resolute · Reveal LINQ · SELECTSECURE · SQ RX · SQ RX PULSE GENERATOR · Solia · Sotalol Hydrochloride · TENDRIL · TactiCath Quartz CFA Catheter · Vascepa · ViewMate Intracardiac Echo · Visia AF · Visitag · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for cardiovascular disease in TX.
Equivalent to $2,188 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
392
Per 100K population
8.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Drtil is a remote & electrophysiology specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (consulting-driven, top 4%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Drtil experienced with evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days?
Based on Medicare claims data, Dr. Drtil performed 816 evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Drtil receive payments from pharmaceutical companies?
Yes. Dr. Drtil received a total of $156,278 from 21 companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Drtil's costs compare to other cardiovascular diseases in Houston?
Dr. Drtil's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Drtil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology